U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. WCBP 2025: The 29th Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Health Products - 01/28/2025
  1. FDA Meetings, Conferences and Workshops

Symposium | Mixed

Event Title
WCBP 2025: The 29th Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Health Products
January 28 - 30, 2025

Scheduled
Date:
January 28 - 30, 2025
Time:
8:00 a.m. - 5:30 p.m. ET
Image
An image containing the WCBP 2025 event logo with the U.S. Capitol building in the background. The event dates on the image are listed as January 28-30.

Organized/Co-sponsored By: CASSS & FDA

January 28-30, 2025
8:00 AM - 5:30 PM ET

Agenda/Scientific Program | Registration

With its 29th arrival, the WCBP Symposium has established a reputation as the highly regarded annual forum for bringing together industry, regulatory, and academic professionals to discuss the role of current and emerging manufacturing and analytical technologies among evolving US and international regulatory landscapes, with the aim to promote development of biotechnology-derived therapeutics.

The theme for WCBP 2025 is "Transformative Solutions" which will include identifying critical barriers and searching for the most inventive and diverse solutions to sustainably meet the needs of patients, as well as highlighting the amplifying role of this forum to promoting collaboration between stakeholders and achieving global impact.

Hear from and engage with thought leaders on a wide range of topics including breakthrough technologies and innovative analytical methodologies; alternative potency assays for various product classes; the use of prior knowledge and hidden potential of established analytical technologies; control strategies for combination products; immunogenicity risk and control; microbiological considerations; leveraging contract organization networks; sustainability; and navigating the small business landscape. The Global Regulatory Panel featuring the Heads of Regulatory Agencies and Health Organizations will discuss regulatory reliance progress, future of biopharmaceutical manufacturing, and global convergence, with discussion to be continued during the Reliance plenary session. Be ready to network, collaborate, and expand your knowledge.

LOCATION

The Mayflower Hotel
1127 Connecticut Avenue NW
Washington D.C. 20036

Back to Top